Adagio Medical raises $42.5m in Series E to transform cardiac ablation treatment
Adagio Medical, a California-based medical device company specializing in innovative treatments for atrial fibrillation (AF) and ventricular tachycardia (VT), has successfully raised $42.5 million in ... Read More